Logo

Vol. 127, No. 10

October 30, 2017
On this page
Need for more action when young hearts are broken
Loukianos S. Rallidis
Pol Arch Intern Med. 2017, Vol. 127, No. 10: 648–649; DOI: 10.20452/pamw.4122
The economics of biological therapy for inflammatory bowel disease and the case for equality
Christian Selinger, Barry Hall
Pol Arch Intern Med. 2017, Vol. 127, No. 10: 650–651; DOI: 10.20452/pamw.4130
Adherence to the guidelines on the management of systolic heart failure in ambulatory care in Poland. Data from the international QUALIFY survey
Grzegorz Opolski, Krzysztof Ozierański, Małgorzata Lelonek, Paweł Balsam, Arleta Wilkins, Piotr Ponikowski, on behalf of the Polish QUALIFY Investigators
Pol Arch Intern Med. 2017, Vol. 127, No. 10: 657–665; DOI: 10.20452/pamw.4083
Behçet disease: a rare systemic vasculitis in Poland
Krzysztof Kanecki, Aneta Nitsch-Osuch, Paweł Goryński, Patryk Tarka, Anna Kutera, Piotr Tyszko
Pol Arch Intern Med. 2017, Vol. 127, No. 10: 652–656; DOI: 10.20452/pamw.4091
Treatment and outcomes of patients under 40 years of age with acute myocardial infarction in Poland in 2009–2013: an analysis from the PL‑ACS registry
Przemysław Trzeciak, Marek Gierlotka, Lech Poloński, Mariusz Gąsior
Pol Arch Intern Med. 2017, Vol. 127, No. 10: 666–673; DOI: 10.20452/pamw.4092
Possible undertreatment of women with Crohn disease in Poland. A subgroup analysis from a prospective multicenter study of patients on anti–tumor necrosis factor therapy
Piotr Eder, Maria Kłopocka, Maria Wiśniewska-Jarosińska, Renata Talar-Wojnarowska, Dariusz Maj, Iga Detka-Kowalska, Jarosław Kierkuś, Andrzej Śliwczyński, Ariel Liebert, Marek Bugajski, Maciej Gonciarz, Edyta Zagórowicz
Pol Arch Intern Med. 2017, Vol. 127, No. 10: 674–680; DOI: 10.20452/pamw.4095
Modification of cardiovascular pharmacotherapy in palliative care patients with cancer: a narrative review
Tomasz Pasierski
Pol Arch Intern Med. 2017, Vol. 127, No. 10: 687–693; DOI: 10.20452/pamw.4098
An update on the management of latent tuberculosis infection and active disease in patients with chronic kidney disease
Katherine Myall, Heather June Milburn
Pol Arch Intern Med. 2017, Vol. 127, No. 10: 681–686; DOI: 10.20452/pamw.4093
Primary sarcoma of the heart
Bartosz Hudzik, Janusz Szkodziński, Barbara Zubelewicz‑Szkodzińska, Mariusz Gąsior
Pol Arch Intern Med. 2017, Vol. 127, No. 10: 694–695; DOI: 10.20452/pamw.4121
An unexpected cause of acute intestinal obstruction: the major role of imaging
Adriana M. Iliesiu, Daniela Stan, Irina Parvu, Andreea S. Hodorogea, Radu A. Stanescu, Daniel G. Radavoi
Pol Arch Intern Med. 2017, Vol. 127, No. 10: 696–697; DOI: 10.20452/pamw.4120
Early onset and persistent progression of coronary artery disease of unknown etiology in a 30‑year‑old man
Jacek Piątek, Anna Kędziora, Justyna Ulańska‑Poutanen, Janusz Konstanty‑Kalandyk, Bryan HyoChan Song, Bogusław Kapelak
Pol Arch Intern Med. 2017, Vol. 127, No. 10: 698–700; DOI: 10.20452/pamw.4131
Solitary retroperitoneal neurofibroma: not as small as it seems
Krzysztof Dąbkowski, Wojciech Marlicz, Krzysztof Kaseja, Marcin Sawicki, Piotr Waloszczyk, Teresa Starzyńska
Pol Arch Intern Med. 2017, Vol. 127, No. 10: 701–702; DOI: 10.20452/pamw.4128
The safety and utility of magnetic resonance imaging in a patient with conventional cardiac resynchronization therapy device
Mateusz Ulman, Andrzej Ząbek, Barbara Małecka, Anna Wasilewska, Michał Michalski, Małgorzata Urbańczyk‑Zawadzka
Pol Arch Intern Med. 2017, Vol. 127, No. 10: 703–704; DOI: 10.20452/pamw.4126
Autologous artificial tears used for treatment of dry eye syndrome in patients with chronic graft versus host disease
Jolanta Antoniewicz‑Papis, Elżbieta Lachert, Karolina Janik, Magdalena Łętowska
Pol Arch Intern Med. 2017, Vol. 127, No. 10: 705–707; DOI: 10.20452/pamw.4127
Association of skin autofluorescence with periodontal inflammation in adults with type 1 diabetes
Anna Duda‑Sobczak, Jakub Lipski, Mateusz Tarnowski, Anna Surdacka, Dorota Zozulińska‑Ziółkiewicz, Marzena Wyganowska‑Świątkowska
Pol Arch Intern Med. 2017, Vol. 127, No. 10: 708–711; DOI: 10.20452/pamw.4129
Omalizumab is effective and available for treatment of patients with severe allergic asthma in Poland
Weronika Zastrzeżyńska, Agnieszka Gawlewicz‑Mroczka, Jerzy Soja, Krzysztof Sładek, Jacek Musiał, Stanisława Bazan‑Socha
Pol Arch Intern Med. 2017, Vol. 127, No. 10: 715–717; DOI: 10.20452/pamw.4132
Whole­ person care: a hope for modern medicine?
Małgorzata Krajnik
Pol Arch Intern Med. 2017, Vol. 127, No. 10: 712–714; DOI: 10.20452/pamw.4100